KIE Director Maggie Little and colleagues, funded by the UK’s Wellcome Trust, have published ethical guidelines to responsibly and equitably include pregnant women in research related to public health emergencies, especially Zika.
Work by a research team headed by KIE Director Maggie Little focused on pregnancy health ethics was recently referenced in a paper highlighting prominent work on the issue.
Dr. Maggie Little briefs a group at the US National Institutes of Health NIAID working to design a clinical development plan for testing a new malaria vaccine in pregnant women.
This week, the PHASES/Zika pregnancy ethics grant team heads to Buenos Aires for a series of international meetings and presentations.
Maggie Little was invited to brief Georgetown leadership on the Zika virus epidemic and her grant-funded work on the ethics of vaccination and treatment.
Dr. Maggie Little will travel with the PHASES/Zika pregnancy ethics grant team to Argentina in November to deliver the GFBR keynote address.
Dr. Anne Drapkin Lyerly will share work from the grant-funded PHASES project, whose core team includes KIE Director Maggie Little as co-principal investigator, at an upcoming conference.
KIE Director Maggie Little will join a panel of experts to identify priorities for the global health and research communities regarding the Zika virus at the upcoming annual American Society for Bioethics and Humanities (ASBH) conference.
Maggie Little offers her perspective on the crisis of uncertainty facing women who must take prescription drugs during pregnancy.
Senior Research Scholar and Institute Director Maggie Little is featured as part of an in-depth segment focused on pregnancy and research.
Pregnancy & HIV/AIDS: Seeking Equitable Study (PHASES) team members visit Durban for a series of consultations with local experts, and to present at the AIDS 2016 conference.
With a £1.2 million grant from the Wellcome Trust, Director Maggie Little and a team of other experts will help provide advice on pregnant women with the Zika virus.
Student newspaper The Hoya profiles some members of the KIE team associated with the recent multi-million dollar NIH grant the Institute received for the ethical inclusion of pregnant women in HIV research.
A $3.6 million grant from the National Institute of Health (NIH) to Georgetown and three other universities will fund a project aimed at improving the health of one of the most vulnerable patient groups in the world – pregnant women with HIV.
Specialists on the ethics of clinical research visited the KIE’s EthicsLab as part of a year-long NIH-funded project on HIV research during pregnancy.
Inspired by work done by KIE director Maggie Little and colleagues on the Second Wave Initiative on research during pregnancy, two JHU graduate students presented research at the Women’s Health Annual Congress in Washington, DC.
Thirty-six members of Congress have joined their voices with the KIE-led Second Wave Initiative in demanding that the government ensure that more pregnant women are responsibly included as medical research subjects.
KIE scholars Maggie Little and Ruth Faden are spearheading the Second Wave Initiative, which aims to address the under-representation of pregnant women and their interests in medical research. This week, they submitted a brief to the US Department of Health and Human Services to consider five proposed recommendations to this effect.